| 000 | 01266 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513034020.0 | ||
| 264 | 0 | _c19950818 | |
| 008 | 199508s 0 0 eng d | ||
| 022 | _a1040-8711 | ||
| 024 | 7 |
_a10.1097/00002281-199505000-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVallance, D K | |
| 245 | 0 | 0 |
_aImmunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis. _h[electronic resource] |
| 260 |
_bCurrent opinion in rheumatology _cMay 1995 |
||
| 300 |
_a174-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAutoantibodies _xanalysis |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclophosphamide _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLung Diseases, Interstitial _xdrug therapy |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xdrug therapy |
| 700 | 1 | _aLynch, J P | |
| 700 | 1 | _aMcCune, W J | |
| 773 | 0 |
_tCurrent opinion in rheumatology _gvol. 7 _gno. 3 _gp. 174-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002281-199505000-00004 _zAvailable from publisher's website |
| 999 |
_c7611841 _d7611841 |
||